SDPA 2024 Annual Fall Dermatology Conference
Another great Society of Dermatology Physician Associates - SDPA conference in the books! ๐Last week our editorial team attended the SDPA 2024 Annual Fall Dermatology Conference in Las Vegas. We sat in on informative lectures and connected with industry leaders, including Conference Medical Director Dr. Hilary Baldwin. We look forward to future SDPA conference coverage. ๐ Check back for detailed conference coverage at PracticalDermatology.com ๐
Another great @derm_pa conference in the books! ๐
Last week our editorial team attended the SDPA 2024 Annual Fall Dermatology Conference in Las Vegas. We sat in on informative lectures and connected with industry leaders, including Conference Medical Director Dr. Hilary Baldwin. We look forward to future SDPA conference coverage.
Detailed conference coverage will soon be available at the link in our bio.
#SDPA #Dermatology #LasVegas
We're offering a special registration discount for Genesis: Innovations in Aesthetic Regenerative Medicine on December 7 in New York City. Don't miss the chance to attend this one-day event with course directors Drs. Shino Bay Aguilera and Doris Day.
Register with the code EARLYBIRD24 for $100 off: https://genesisarm.com/
*Offer ends on September 15*
๐จ We're offering a special registration discount for Genesis: Innovations in Aesthetic Regenerative Medicine on December 7 in New York City. Don't miss the chance to attend this one-day event with course directors Drs. Shino Bay Aguilera and Doris Day.
Register with the code EARLYBIRD24 for $100 off: https://genesisarm.com/
*Offer ends on September 15*
๐ฃ Attention Industry Leaders - Exciting Announcement!
Join us for the 2nd Annual Tell-All Tribune: An Aesthetic Think Tank meeting scheduled for June 19-21, 2025 in Fort Lauderdale, Florida.
Dr Shino Bay Aguilera is once again hosting an invitation-only think tank, where the top aesthetics providers in the country come together to discuss, debate, educate, and learn from each other. By exchanging ideas, sharing experiences, and collaborating, we aim to further the industry. This unique gathering of thought leaders provides a platform for breakthroughs and visionary insights, which will be shared through Modern Aesthetics print and digital platform.
Sponsorship available at all levels. Donโt miss out on this unique opportunity to network and showcase your brand! #Aesthetics #ThinkTank #TAT #IndustryLeaders #Innovation #Networking #Visionary #SponsorshipOpportunities
Anna Bar, MD, summarizes her lectures on surgical procedures at the 2024 Noah Worcester Dermatological Society meeting. https://bit.ly/45lpFJE
Alina Bridges, DO, FAAD, summarizes her lecture on practice management and coding at the 2024 Noah Worcester Dermatological Society meeting. Watch on here: https://bit.ly/3VrKQ9C
Peter Lio, MD, talks with Robert Sidbury, MD, MPH, a dermatologist at Seattle Children's Hospital, about nuanced differences in guideline-recommended use of oral JAK inhibitors in pediatric patients with moderate-to-severe atopic dermatitis (AD) provided in the Annals of Allergy, Asthma, and Immunology Joint Task Force AD guidelines and the Journal of the American Academy of Dermatology AD guidelines. Continue watching here: https://bit.ly/4e59O60
In this episode of DermWire TV, a new analysis highlights factors affecting long-term antibiotic prescriptions for acne; a company developing plaque psoriasis biologics makes a major acquisition; and Practical Dermatology launches two new video series focusing on advancing treatment and improving understanding of atopic dermatitis. (AD), as well as a new series of C-Suite interviews. Continue watching here: https://bit.ly/3Jh8O0s
Dermatologists discuss Valisure report on benzene in acne products, FDA approves glabellar lines treatment, and PA Perspectives series on contracting. Watch our latest episode of DermWireTV: https://bit.ly/3VG9T9K
In this episode of DermWireTV, a phase 3 study finds roflumilast cream is associated with significantly improved atopic dermatitis in children; first-of-its-kind research suggests that eczema treatment lebrikizumab shows efficacy and safety in patients with skin of color; and new data reveals oral JAK1 inhibitor povorcitinib improves itch in people with prurigo nodularis. Watch more here: https://bit.ly/3wPceVe
Mark Birch-Machin, PhD, a professor of molecular dermatology at New Castle University, talks about the effects that air pollution can have on skin. Dr. Birch-Machin also talks about a recent study his team published in FASEB BioAdvances looking at the effects of air pollution on human skin equivalents, as well as what can be done to reverse damage caused by ozone. Watch more here: https://bit.ly/3TJXwYV
A monthly publication that provides coverage of medical care, cosmetic advancements, and practice management for clinicians in the field.
